Full-Life Technologies
Clinical-stage radiotherapeutics company developing targeted cancer therapies with integrated isotope manufacturing
$150MSeries D+Debt
Role not disclosedJC
Junson Capital
Activity from announced rounds
Activity in this selectionj-p-morgan-life-sciences-private-capital-2d7805a5
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $171M 2 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
2 in this selectionButterfly Medical
Develops a minimally invasive implantable device to treat benign prostatic hyperplasia in men
$21MSeries C
Role not disclosed